Literature DB >> 11120767

HLA-DM recognizes the flexible conformation of major histocompatibility complex class II.

C L Chou1, S Sadegh-Nasseri.   

Abstract

DM facilitates formation of high affinity complexes of peptide-major histocompatibility complex (MHC) by release of class II MHC-associated invariant chain peptide (CLIP). This has been proposed to occur through discrimination of complex stability. By probing kinetic and conformational intermediates of the wild-type and mutant human histocompatibility leukocyte antigen (HLA)-DR1-peptide complexes, and examining their reactivities with DM, we propose that DM interacts with the flexible hydrophobic pocket 1 of DR1 and converts the molecule into a conformation that is highly peptide receptive. A more rigid conformation, generated upon filling of pocket 1, is less susceptible to DM effects. Thus, DM edits peptide-MHC by recognition of the flexibility rather than stability of the complex.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11120767      PMCID: PMC2213500          DOI: 10.1084/jem.192.12.1697

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  45 in total

1.  Mediation by HLA-DM of dissociation of peptides from HLA-DR.

Authors:  V S Sloan; P Cameron; G Porter; M Gammon; M Amaya; E Mellins; D M Zaller
Journal:  Nature       Date:  1995-06-29       Impact factor: 49.962

2.  Structures of an MHC class II molecule with covalently bound single peptides.

Authors:  D H Fremont; W A Hendrickson; P Marrack; J Kappler
Journal:  Science       Date:  1996-05-17       Impact factor: 47.728

3.  HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading.

Authors:  L K Denzin; P Cresswell
Journal:  Cell       Date:  1995-07-14       Impact factor: 41.582

4.  Measuring interactions of MHC class I molecules using surface plasmon resonance.

Authors:  S N Khilko; M T Jelonek; M Corr; L F Boyd; A L Bothwell; D H Margulies
Journal:  J Immunol Methods       Date:  1995-06-14       Impact factor: 2.303

5.  High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations.

Authors:  J Hammer; C Belunis; D Bolin; J Papadopoulos; R Walsky; J Higelin; W Danho; F Sinigaglia; Z A Nagy
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

6.  DM enhances peptide binding to class II MHC by release of invariant chain-derived peptide.

Authors:  M A Sherman; D A Weber; P E Jensen
Journal:  Immunity       Date:  1995-08       Impact factor: 31.745

7.  A general model of invariant chain association with class II major histocompatibility complex proteins.

Authors:  C Lee; H M McConnell
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-29       Impact factor: 11.205

8.  Antigen presentation and assembly by mouse I-Ak class II molecules in human APC containing deleted or mutated HLA DM genes.

Authors:  A G Brooks; P L Campbell; P Reynolds; A M Gautam; J McCluskey
Journal:  J Immunol       Date:  1994-12-15       Impact factor: 5.422

9.  The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent.

Authors:  C C Stebbins; G E Loss; C G Elias; A Chervonsky; A J Sant
Journal:  J Exp Med       Date:  1995-01-01       Impact factor: 14.307

10.  The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy.

Authors:  P Romagnoli; R N Germain
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307

View more
  56 in total

1.  The kinetic basis of peptide exchange catalysis by HLA-DM.

Authors:  J A Zarutskie; R Busch; Z Zavala-Ruiz; M Rushe; E D Mellins; L J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

2.  Conformational lability in the class II MHC 310 helix and adjacent extended strand dictate HLA-DM susceptibility and peptide exchange.

Authors:  Corrie A Painter; Maria P Negroni; Katherine A Kellersberger; Zarixia Zavala-Ruiz; James E Evans; Lawrence J Stern
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

3.  DM influences the abundance of major histocompatibility complex class II alleles with low affinity for class II-associated invariant chain peptides via multiple mechanisms.

Authors:  Cornelia H Rinderknecht; Sujin Roh; Achal Pashine; Michael P Belmares; Namrata S Patil; Ning Lu; Phi Truong; Tieying Hou; Claudia Macaubas; Taejin Yoon; Nan Wang; Robert Busch; Elizabeth D Mellins
Journal:  Immunology       Date:  2010-04-12       Impact factor: 7.397

4.  Small molecules that enhance the catalytic efficiency of HLA-DM.

Authors:  Melissa J Nicholson; Babak Moradi; Nilufer P Seth; Xuechao Xing; Gregory D Cuny; Ross L Stein; Kai W Wucherpfennig
Journal:  J Immunol       Date:  2006-04-01       Impact factor: 5.422

Review 5.  The convergent roles of tapasin and HLA-DM in antigen presentation.

Authors:  Scheherazade Sadegh-Nasseri; Mingnan Chen; Kedar Narayan; Marlene Bouvier
Journal:  Trends Immunol       Date:  2008-02-07       Impact factor: 16.687

Review 6.  Understanding the focused CD4 T cell response to antigen and pathogenic organisms.

Authors:  Jason M Weaver; Andrea J Sant
Journal:  Immunol Res       Date:  2009-02-07       Impact factor: 2.829

7.  Structural Insights Into HLA-DM Mediated MHC II Peptide Exchange.

Authors:  Corrie A Painter; Lawrence J Stern
Journal:  Curr Top Biochem Res       Date:  2011

Review 8.  Selection of immunodominant epitopes during antigen processing is hierarchical.

Authors:  Scheherazade Sadegh-Nasseri; AeRyon Kim
Journal:  Mol Immunol       Date:  2018-08-24       Impact factor: 4.407

Review 9.  HLA-DM and HLA-DO, key regulators of MHC-II processing and presentation.

Authors:  Elizabeth D Mellins; Lawrence J Stern
Journal:  Curr Opin Immunol       Date:  2013-12-08       Impact factor: 7.486

Review 10.  Exogenous antigens bind MHC class II first, and are processed by cathepsins later.

Authors:  Scheherazade Sadegh-Nasseri; AeRyon Kim
Journal:  Mol Immunol       Date:  2015-08-05       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.